189 related articles for article (PubMed ID: 26546192)
1. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
Huang SM; Liao WT; Lin CF; Sun HS; Chow NH
World J Surg; 2016 Mar; 40(3):505-9. PubMed ID: 26546192
[TBL] [Abstract][Full Text] [Related]
2. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease.
Erbil Y; Ozluk Y; Giriş M; Salmaslioglu A; Issever H; Barbaros U; Kapran Y; Ozarmağan S; Tezelman S
J Clin Endocrinol Metab; 2007 Jun; 92(6):2182-9. PubMed ID: 17389702
[TBL] [Abstract][Full Text] [Related]
3. [Ultrasonographic evaluation of thyroid tissue perfusion in patients with Graves-Basedow disease as preparation for surgery].
Rogula T; Cichoń S
Folia Med Cracov; 2000; 41(3-4):121-9. PubMed ID: 11339007
[TBL] [Abstract][Full Text] [Related]
4. Utility of colour Doppler sonography in patients with Graves' disease.
Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
[TBL] [Abstract][Full Text] [Related]
5. The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
Erbil Y; Giriş M; Salmaslioglu A; Ozluk Y; Barbaros U; Yanik BT; Kapran Y; Abbasoglu SD; Ozarmagan S
Surgery; 2008 Feb; 143(2):216-25. PubMed ID: 18242338
[TBL] [Abstract][Full Text] [Related]
6. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
Reddy A; Chand G; Mayilvaganan S
World J Surg; 2017 Jan; 41(1):333. PubMed ID: 26913729
[No Abstract] [Full Text] [Related]
8. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease: Reply.
Huang SM
World J Surg; 2017 Jan; 41(1):334. PubMed ID: 27189073
[No Abstract] [Full Text] [Related]
9. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter.
Ansaldo GL; Pretolesi F; Varaldo E; Meola C; Minuto M; Borgonovo G; Derchi LE; Torre GC
J Am Coll Surg; 2000 Dec; 191(6):607-12. PubMed ID: 11129808
[TBL] [Abstract][Full Text] [Related]
10. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
[TBL] [Abstract][Full Text] [Related]
11. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
[TBL] [Abstract][Full Text] [Related]
12. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Manetti L; Tanda ML; Gasperi M; Martino E
Eur J Endocrinol; 1999 May; 140(5):452-6. PubMed ID: 10229913
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
14. Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
Fischli S; Lucchini B; Müller W; Slahor L; Henzen C
Swiss Med Wkly; 2016; 146():w14243. PubMed ID: 26765838
[TBL] [Abstract][Full Text] [Related]
15. The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves disease.
Huang SM; Chow NH; Lee HL; Wu TJ
Arch Surg; 2003 Feb; 138(2):146-51; discussion 151. PubMed ID: 12578408
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for intraoperative excessive bleeding in Graves' disease.
Yamanouchi K; Minami S; Hayashida N; Sakimura C; Kuroki T; Eguchi S
Asian J Surg; 2015 Jan; 38(1):1-5. PubMed ID: 24938857
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative management of patients with Graves' disease.
Chen H
Surgery; 2008 Feb; 143(2):292-3. PubMed ID: 18242347
[No Abstract] [Full Text] [Related]
18. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism.
Chang DC; Wheeler MH; Woodcock JP; Curley I; Lazarus JR; Fung H; John R; Hall R; McGregor AM
Surgery; 1987 Dec; 102(6):1055-61. PubMed ID: 3317958
[TBL] [Abstract][Full Text] [Related]
19. Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism.
Rangaswamy M; Padhy AK; Gopinath PG; Shukla NK; Gupta K; Kapoor MM
Nucl Med Commun; 1989 Sep; 10(9):679-84. PubMed ID: 2616107
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
